Safety Information


CO2 Products

CO2 lasers are intended solely for use by physicians trained in the use of the Carbon Dioxide laser (10.6 μm) wavelength. Incorrect treatment settings or misuse of the technology can present risk of serious injury to patient and operating personnel. Risks that may be associated with any CO2 laser procedure may include change of pigmentation, infection, erythema, skin induration or scarring. Read and understand the CO2 systems and accessories operator manuals for a complete list of intended use, contraindications and risks. The use of Lumenis CO2 laser is contraindicated where a patient has taken Accutane (Isotretinoin) within the past 6-12 months, has a history of keloid formation and demonstrate excessive or unusually prolonged erythema.


M22 is contraindicated for patients with active infection, viral, fungal or bacterial diseases. The use of M22 could cause redness, swelling, scarring, change of pigmentation. See the system user manual for a complete list of contraindications and risks.


Treatment should not be attempted on patients with the following conditions in the treatment area: any active infections or inflammatory skin conditions, Dysplastic nevi, tattoos, active cold sores, open lacerations or abrasions, viral, fungal, or bacterial diseases or a history of post inflammatory hyperpigmentation. The most common immediate responses of laser treatment for hair removal, vascular lesions, pigmented lesions are erythema, edema, perifollicular edema and perivascular edema, vascular bleaching, hyperpigmentation and hypopigmentation or textural changes of the treated areas. The complete list of contraindications and risks can be found in the LigthSheer system user manual.